Results 31 to 40 of about 32,701 (226)

Alpha-1 antitrypsin deficiency: clarifying the role of the putative protective threshold

open access: yesEuropean Respiratory Journal, 2021
Alpha-1 antitrypsin deficiency (AATD) is the only readily identifiable monogenic cause of COPD. To date the only condition-specific treatment for AATD-associated COPD is weekly administration of intravenous plasma-purified human alpha-1 antitrypsin (IV ...
A. Franciosi   +3 more
semanticscholar   +1 more source

Update on and future perspectives for the diagnosis of alpha-1 antitrypsin deficiency in Brazil

open access: yesJornal Brasileiro de Pneumologia, 2021
Alpha-1 antitrypsin deficiency (AATD) is a rare genetic disorder caused by a mutation in the SERPINA1 gene, which encodes the protease inhibitor alpha-1 antitrypsin (AAT). Severe AATD predisposes individuals to COPD and liver disease.
José R Jardim   +5 more
doaj   +2 more sources

The spectrum of clinical sequelae associated with alpha-1 antitrypsin deficiency

open access: yesTherapeutic Advances in Chronic Disease, 2021
Alpha-1 antitrypsin (AAT) deficiency (AATD) is an autosomal co-dominant condition that predisposes to the development of lung disease, primarily emphysema.
V. Tejwani, J. Stoller
semanticscholar   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

The Mechanism of Mitochondrial Injury in Alpha-1 Antitrypsin Deficiency Mediated Liver Disease

open access: yesInternational Journal of Molecular Sciences, 2021
Alpha-1 antitrypsin deficiency (AATD) is caused by a single mutation in the SERPINA1 gene, which culminates in the accumulation of misfolded alpha-1 antitrypsin (ZAAT) within the endoplasmic reticulum (ER) of hepatocytes.
N. Khodayari   +9 more
semanticscholar   +1 more source

ALPHA-1-ANTITRYPSIN DEFICIENCY IN CHILDREN

open access: yesМедицинский совет, 2017
Hereditary deficiency of the alpha-1-antitrypsin occupies a leading position among the causes of chronic nonspecific lung diseases with emphysema formation.
S. I. MELNIK   +5 more
doaj   +1 more source

The undiagnosed disease burden associated with alpha-1 antitrypsin deficiency genotypes

open access: yesEuropean Respiratory Journal, 2020
Alpha-1 antitrypsin deficiency (AATD), mainly due to the PI*ZZ genotype in SERPINA1, is one of the most common inherited diseases. Since it is associated with a high disease burden and partially prevented by smoking cessation, identification of PI*ZZ ...
T. Nakanishi   +7 more
semanticscholar   +1 more source

Severe alpha‐1‐antitrypsin deficiency increases the risk of venous thromboembolism

open access: yesJournal of Thrombosis and Haemostasis, 2021
Severe alpha‐1‐antitrypsin deficiency (AATD), phenotype PiZZ, is associated with increased risk of liver disease and chronic obstructive pulmonary disease (COPD), but the risk of venous thromboembolism (VTE) is unknown.
Nawfal Basil   +6 more
semanticscholar   +1 more source

alpha 1-antitrypsin deficiency.

open access: yesMonaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 1998
Homozygous PIZZ alpha 1-antitrypsin deficiency, which has an incident of 1 in 1600 to 1 in 2000 live births, is the most common genetic cause of liver disease in children. It is also associated with chronic liver disease and hepatocellular carcinoma in adults. It is a well-known cause of pulmonary emphysema.
Paone G, Brantly M.
openaire   +5 more sources

Future Perspectives in the Diagnosis and Treatment of Liver Disease Associated with Alpha-1 Antitrypsin Deficiency

open access: yesGE: Portuguese Journal of Gastroenterology, 2023
Alpha-1 antitrypsin deficiency (AATD) is one of the most common genetic diseases and is caused by mutations in the SERPINA1 gene. The homozygous Pi*Z variant is responsible for the majority of the classic severe form of alpha-1 antitrypsin deficiency ...
Nélia Abreu   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy